Finding a place for tumor-specific T cells in targeted cancer therapy (Q35990075)

11 August 2017

10 references

3 April 2019

19 June 2019

25 June 2019

3 August 2019

9 August 2019

19 September 2019

12 October 2019

18 October 2019

1 August 2020

8 February 2021

Finding a place for tumor-specific T cells in targeted cancer therapy (English)

1 reference

biomedical investigative technique

11 August 2017

2 references

3 April 2019

19 June 2019

1 reference

3 August 2019

1 reference

9 August 2019

1 reference

19 September 2019

1 reference

12 October 2019

hemic and immune systems

1 reference

18 October 2019

adoptive immunotherapy

1 reference

1 August 2020

1 reference

8 February 2021

Stanley R Riddell

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Journal of Experimental Medicine

11 August 2017

20 December 2004

10 references

3 April 2019

19 June 2019

25 June 2019

3 August 2019

9 August 2019

19 September 2019

12 October 2019

18 October 2019

1 August 2020

8 February 2021

11 references

11 August 2017

3 April 2019

19 June 2019

25 June 2019

3 August 2019

9 August 2019

19 September 2019

12 October 2019

18 October 2019

1 August 2020

8 February 2021

200

1 reference

11 August 2017

12

1 reference

11 August 2017

1533-1537

1 reference

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Epstein-Barr virus: 40 years on

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Cancer immunotherapy: a treatment for the masses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Molecules and mechanisms of the graft-versus-leukaemia effect

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Adoptive-cell-transfer therapy for the treatment of patients with cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Progressive differentiation and selection of the fittest in the immune response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

A new era for cancer immunotherapy based on the genes that encode cancer antigens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

11 July 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20042004

Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20042004

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20042004

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20042004

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20042004

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2212006

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

24 September 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20042004

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/15611285

12 December 2020

inferred from PubMed ID database lookup

Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15611285

12 December 2020

inferred from PubMed ID database lookup

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1 reference

https://pubmed.ncbi.nlm.nih.gov/15611285

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1084/JEM.20042004

1 reference

release_uj4tudhl7rhozgi77csx572glq

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uj4tudhl7rhozgi77csx572glq

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

PubMed publication ID

15611285

1 reference